The Cockrell Group, a leading healthcare-focused investor relations firm, today announced that it has been engaged by Vision-Sciences, Inc. (NASDAQ: VSCI), the company designs, develops, manufactures and markets unique flexible endoscopic products utilizing sterile disposable sheaths.
“We will continue to develop Vision-Sciences' investor relations program,” said Rich Cockrell, President of the Cockrell Group. “I believe that Vision-Sciences’ technology represents a compelling investment idea and we look forward to increasing the Company’s visibility through the introduction to new investors. I am confident that our firm will execute well on behalf of Vision-Sciences’ shareholders."
About The Cockrell Group
The Cockrell Group, Inc. is a strategic investor relations and corporate access firm focused on small-to-midcap companies in healthcare. It aligns a company's strategic goals to an institution's investment thesis and fundamentals to create a sound, long-term investment objective. The company also advises companies in various areas, including private and pre-IPO activity, mergers and acquisitions, bankruptcy, executive transitions, activist shareholders, hostile takeovers, and downsizing, as well as manages events.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets unique flexible endoscopic products utilizing sterile disposable sheaths, the Slide-On EndoSheath System, which provide the users quick, efficient product turnover while ensuring the patient a contaminant-free product.
Vision-Sciences owns the registered trademarks Vision Sciences®, Slide-On®, EndoSheath®, EndoWipe® and The Vision System®. Information about Vision-Sciences' products is available at